Diabetes and CKD in the United States Population, 2009–2014
Open Access
- 20 October 2017
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of the American Society of Nephrology
- Vol. 12 (12), 1984-1990
- https://doi.org/10.2215/cjn.03700417
Abstract
Background and objectives Diabetes is an important cause of CKD. However, among people with diabetes, it is unclear to what extent CKD is attributable to diabetes itself versus comorbid conditions, such as advanced age and hypertension. We examined associations of diabetes with clinical manifestations of CKD independent of age and BP and the extent to which diabetes contributes to the overall prevalence of CKD in the United States. Design, setting, participants, & measurements We performed a cross-sectional study of 15,675 participants in the National Health and Nutrition Examination Surveys from 2009 to 2014. Diabetes was defined by use of glucose-lowering medications or hemoglobin A1c ≥6.5%. eGFR was calculated using the CKD Epidemiology Collaboration formula, and albumin-to-creatinine ratio was measured in single-void urine samples. We calculated the prevalence of CKD manifestations by diabetes status as well as prevalence ratios, differences in prevalence, and prevalence attributable to diabetes using binomial and linear regression, incorporating data from repeat eGFR and urine albumin-to-creatinine ratio measurements to estimate persistent disease. Results For participants with diabetes (n=2279) versus those without diabetes (n=13,396), the estimated prevalence of any CKD (eGFR2; albumin-to-creatinine ratio ≥30 mg/g, or both) was 25% versus 5.3%, respectively; albumin-to-creatinine ratio ≥30 mg/g was 16% versus 3.0%, respectively; albumin-to-creatinine ratio ≥300 mg/g was 4.6% versus 0.3%, respectively; eGFR2 was 12% versus 2.5%, respectively; and eGFR2 was 2.4% versus 0.4%, respectively (each PPPPPP=0.004), respectively. Approximately 24% (95% confidence interval, 19% to 29%) of CKD among all United States adults was attributable to diabetes after adjusting for demographics. Conclusions Diabetes is strongly associated with both albuminuria and reduced GFR independent of demographics and hypertension, contributing substantially to the burden of CKD in the United States.Keywords
This publication has 22 references indexed in Scilit:
- Diabetic Kidney Disease: A Report From an ADA Consensus ConferenceDiabetes Care, 2014
- Renal Structure in Normoalbuminuric and Albuminuric Patients With Type 2 Diabetes and Impaired Renal FunctionDiabetes Care, 2013
- Kidney Disease and Increased Mortality Risk in Type 2 DiabetesJournal of the American Society of Nephrology, 2013
- Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysisThe Lancet, 2012
- Temporal Trends in the Prevalence of Diabetic Kidney Disease in the United StatesJama-Journal Of The American Medical Association, 2011
- Measurement of HbA1c from stored whole blood samples in the Atherosclerosis Risk in Communities studyJournal of Diabetes, 2010
- Prevalence of Diabetes and Impaired Fasting Glucose in Adults in the U.S. PopulationDiabetes Care, 2006
- Patterns of renal injury in NIDDM patients with microalbuminuriaDiabetologia, 1996
- Prevalence and causes of albuminuria in non-insulin-dependent diabetic patientsKidney International, 1992
- Structural-functional relationships in diabetic nephropathy.JCI Insight, 1984